Skip to main content

Outset Medical, Inc.

OM
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001484612

In the last 90 days, Outset Medical, Inc. insiders filed 0 open-market purchases and 3 sales; 92 institutions reported holding it in 13F filings for Q2 2026, worth $59.8M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Outset Medical, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
3 filings
3 insiders, $46.6K in total
Insiders trading
3
Net value
−$46.6K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Outset Medical, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Outset Medical, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Trigg LeslieChair and CEO194,597Aug 18, 20267
Brottem John L.General Counsel87,475Aug 18, 20267
Gaeta ReneeChief Financial Officer180,840Aug 18, 20263
Oboyle Kevin CDirector34,785Jun 5, 20261
Grossman D KeithDirector24,585Jun 5, 20261
Hackett Patrick TDirector105,839Jun 5, 20261
Drexler KarenDirector21,317Jun 5, 20262
Lang Brent D.Director28,518Jun 5, 20261
Prange KarenDirector29,334Jun 5, 20262
Nash MarcEVP Operations R&D & Service38,393May 19, 20265
Leonard Braden Michael10% Owner2,519,701IndirectMay 18, 20262
Elliott Derick A.EVP, Commercial96,000Apr 8, 20261
Saia Andrea LynnDirector12,175Jun 4, 20250
Ahmed NabeelChief Financial Officer16,096May 16, 20250
Jones Dale EDirector45,918May 29, 20240
Hinrichs James F.Director80,349May 29, 20240
Racine Jean-OlivierChief Technology Officer265,325May 10, 20240
Williamson Steven S.Chief Commercial Officer320,347Feb 16, 20240
Porter Stacey L.Chief People Officer61,448Jan 17, 20240
Szyman Catherine M.Director24,596May 31, 20230
Vazquez MartinChief Operating Officer103,112Mar 2, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 16, 2025 (view filing)May 151 dayBrottem John L.General CounselSSale−396$17.82−$7.06K−3.4%11.3K after
May 16, 2025 (view filing)May 151 dayNash MarcSVP Operations and R&DSSale−252$17.82−$4.49K−1.8%13.5K after
May 16, 2025 (view filing)May 151 dayTrigg LeslieChair and CEOSSale−935$17.80−$16.6K−1.6%58.1K after
Aug 18, 2025 (view filing)Aug 153 daysBrottem John L.General CounselSSale−383$12.88−$4.93K−0.8%46.9K after
Aug 18, 2025 (view filing)Aug 153 daysNash MarcSVP Operations and R&DSSale−243$12.88−$3.13K−0.6%42.9K after
Aug 18, 2025 (view filing)Aug 153 daysTrigg LeslieChair and CEOSSale−904$12.88−$11.6K−0.7%122.3K after
Nov 18, 2025 (view filing)Nov 171 dayBrottem John L.General CounselSSale−388$4.60−$1.78K−0.8%46.5K after
Nov 18, 2025 (view filing)Nov 171 dayNash MarcEVP Operations R&D & ServiceSSale−247$4.60−$1.14K−0.5%48.3K after
Nov 18, 2025 (view filing)Nov 171 dayTrigg LeslieChair and CEOSSale−916$4.60−$4.21K−0.7%121.4K after
Dec 2, 2025 (view filing)Dec 11 dayDrexler KarenDirectorSSale−1.55K$4.37−$6.76K−12.7%10.7K after
Jan 8, 2026 (view filing)Jan 71 dayTrigg LeslieChair and CEOSSale−1.79K$4.27−$7.66K−1.5%119.6K after
Jan 8, 2026 (view filing)Jan 71 dayBrottem John L.General CounselSSale−224$4.27−$956.48−0.5%46.3K after
Jan 8, 2026 (view filing)Jan 71 dayNash MarcEVP Operations R&D & ServiceSSale−108$4.27−$461.16−0.2%48.2K after
Jan 21, 2026 (view filing)Jan 20-211 dayTrigg LeslieChair and CEOSSale−13.9K$5.11−$71.1K−11.6%105.7K after2 lots
Jan 21, 2026 (view filing)Jan 20-211 dayBrottem John L.General CounselSSale−10.5K$5.11−$53.6K−22.7%35.8K after2 lots
Jan 21, 2026 (view filing)Jan 20-211 dayNash MarcEVP Operations R&D & ServiceSSale−6.36K$5.10−$32.4K−13.2%41.8K after2 lots
Feb 19, 2026 (view filing)Feb 172 daysTrigg LeslieChair and CEOSSale−3.36K$3.35−$11.3K−3.2%102.3K after
Feb 19, 2026 (view filing)Feb 172 daysBrottem John L.General CounselSSale−2.84K$3.35−$9.52K−7.9%32.9K after
Feb 19, 2026 (view filing)Feb 172 daysNash MarcEVP Operations R&D & ServiceSSale−1.82K$3.35−$6.09K−4.3%40.0K after
May 19, 2026 (view filing)May 154 daysBrottem John L.General CounselSSale−2.64K$3.70−$9.76K−8.0%30.3K after
May 19, 2026 (view filing)May 154 daysNash MarcEVP Operations R&D & ServiceSSale−1.58K$3.70−$5.85K−4.0%38.4K after
May 19, 2026 (view filing)May 154 daysTrigg LeslieChair and CEOSSale−3.44K$3.70−$12.7K−3.4%98.9K after
Jun 5, 2026 (view filing)Jun 32 daysGaeta ReneeChief Financial OfficerSSale−17.7K$4.94−$87.3K−13.4%113.8K after
Aug 18, 2026 (view filing)6:46 PM ETAug 171 dayGaeta ReneeChief Financial OfficerSSale−4.54K$4.39−$19.9K−2.5%180.8K after
Aug 18, 2026 (view filing)6:51 PM ETAug 171 dayBrottem John L.General CounselSSale−2.63K$4.39−$11.6K−2.9%87.5K after
Aug 18, 2026 (view filing)7:45 PM ETAug 171 dayTrigg LeslieChair and CEOSSale−3.44K$4.39−$15.1K−1.7%194.6K after